Syneron Medical (ELOS) Reports Q1 Adj-Loss of $0.23
More News related to ELOS
- Syneron Debuts elure(TM) Advanced Dermal Whitening in Asia
- Syneron Medical (ELOS) Posts Q3 Loss of 20c, Misses Views by 5c
- Syneron Reports Third Quarter 2009 Financial Results
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Syneron Medical to Announce Third Quarter 2009 Financial Results on November 9th, 2009
More News related to Earnings
- Holly Energy (HEP) Acquires Roadrunner Pipeline from Holly Corp. (HOC); HEP Mentions Enterprise Products (EPD) Transaction
- Dyax (DYAX) Receives FDA Approval of KALBITOR(R) for Treatment of Acute Attacks of Hereditary Angioedema
- UMB Bank (UMBF) Acquires American National Bank Corporate Trust Business
- Center Financial (CLFC) Raises $12.8M In Private Placement
- Markel (MKL) Acquires Majority Interest in Ellicott Dredge Enterprises
Syneron Medical Ltd. (Nasdaq: ELOS) reports Q1 loss of $0.23, ex-items, versus the analyst estimate of ($0.16). Revenue for the quarter was $11.9 million, versus the consensus of $14.42 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
